Your browser doesn't support javascript.
loading
Mass balance and metabolite profiling of 14C-guadecitabine in patients with advanced cancer.
Roosendaal, Jeroen; Rosing, Hilde; Lucas, Luc; Gebretensae, Abadi; Huitema, Alwin D R; van Dongen, Marloes G; Beijnen, Jos H; Oganesian, Aram.
Afiliación
  • Roosendaal J; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands. j.roosendaal@nki.nl.
  • Rosing H; Division of Pharmacoepidemiology and Clinical Pharmacology, Science Faculty, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. j.roosendaal@nki.nl.
  • Lucas L; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Gebretensae A; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Huitema ADR; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • van Dongen MG; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
  • Beijnen JH; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
  • Oganesian A; Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, The Netherlands.
Invest New Drugs ; 38(4): 1085-1095, 2020 08.
Article en En | MEDLINE | ID: mdl-31605293

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Azacitidina / Neoplasias / Antineoplásicos Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Azacitidina / Neoplasias / Antineoplásicos Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos
...